ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 104 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2016. The put-call ratio across all filers is 3.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $162 | +15.7% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $140 | -0.7% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $141 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 200 | +809.1% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 22 | -99.3% | 0.00% | – |
| Q3 2018 | $73,000 | +2.8% | 3,200 | 0.0% | 0.00% | – |
| Q2 2018 | $71,000 | -2.7% | 3,200 | 0.0% | 0.00% | – |
| Q1 2018 | $73,000 | -13.1% | 3,200 | 0.0% | 0.00% | – |
| Q4 2017 | $84,000 | +16.7% | 3,200 | 0.0% | 0.00% | – |
| Q3 2017 | $72,000 | -18.2% | 3,200 | 0.0% | 0.00% | – |
| Q2 2017 | $88,000 | +14.3% | 3,200 | 0.0% | 0.00% | – |
| Q1 2017 | $77,000 | +16.7% | 3,200 | 0.0% | 0.00% | – |
| Q4 2016 | $66,000 | +247.4% | 3,200 | +357.1% | 0.00% | – |
| Q3 2016 | $19,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,183,795 | $48,699,000 | 33.10% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,274,080 | $95,312,000 | 23.04% |
| Selkirk Management LLC | 341,450 | $7,614,000 | 3.92% |
| NEXT CENTURY GROWTH INVESTORS LLC | 612,106 | $13,649,000 | 1.74% |
| Chicago Capital, LLC | 538,191 | $12,002,000 | 0.97% |
| Cannell & Co. | 1,115,239 | $24,870,000 | 0.93% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $3,457,000 | 0.76% |
| CHARTIST INC /CA/ | 64,765 | $1,444,260,000 | 0.65% |
| PURA VIDA INVESTMENTS, LLC | 70,000 | $1,561,000 | 0.63% |
| ORACLE INVESTMENT MANAGEMENT INC | 607,600 | $2,106,000 | 0.51% |